U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118618) titled 'Probenecid Administration for Alcohol Craving and Consumption' on July 31.
Brief Summary: This study proposes a 16-week, between-subject, double-blind, randomized controlled trial (RCT) with probenecid (2g /day) compared to placebo in individuals with AUD to test if reduces craving and alcohol consumption.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Alcohol Use Disorder (AUD)
Alcohol Consumption
Craving
Intervention:
DRUG: Probenecid Oral Tablet
2gr daily
DRUG: Placebo Oral Tablet
Inactive compound
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Brown University
Information provided by (Responsible P...